Junctophilins emerge as novel therapeutic targets

J Cell Physiol. 2019 Aug;234(10):16933-16943. doi: 10.1002/jcp.28405. Epub 2019 Mar 1.

Abstract

Junctophilins (JPs) emerge to play key role in human pathophysiology. This family includes four subtypes (JP1-4), which are differentially detected in excitable cells. Previous work demonstrated the knockout of JPs that seriously damage physiological functions in skeletal muscle, cardiac, and neurons. Here, we summarize latest papers on the essential function of JPs in some Ca2+ -related diseases and neurological diseases, such as primary muscle disease, cardiomyopathies, Type 2 diabetes, gastrointestinal cancer, Huntington's disease-like 2, and Charcot-Marie-Tooth disease. Growing evidence suggests that targeting JPs might be a promising therapeutic approach to achieve better clinical efficacy in Ca 2+ -related diseases and neurological diseases.

Keywords: Huntington’s disease-like 2; calcium; cardiomyopathy; gastrointestinal cancer; junctophilin.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Calcium Signaling / physiology
  • Diabetes Mellitus, Type 2 / metabolism
  • Gastrointestinal Neoplasms / metabolism
  • Heart Diseases / metabolism
  • Humans
  • Membrane Proteins / physiology*
  • Muscular Diseases / metabolism
  • Nervous System Diseases / metabolism

Substances

  • Membrane Proteins
  • junctophilin